Article Information
History
- November 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alexandre Manirakiza1,2,*,
- Christian Malaka1,
- Brice Martial Yambiyo1,
- Saint-Calver Henri Diemer2,
- Jean de Dieu Longo2,3,
- Joella Namseneï1,
- Cathy Sandra Gomelle Coti-Reckoundji1,
- Modeste Bouhouda1,
- Belizaire Marie Roseline Darnycka4,
- Jean Baptiste Roungou3,
- Narcisse Patrice Komas1,2,
- Gérard Grésenguet2,
- Guy Vernet1,
- Marie-Astrid Vernet1 and
- Emmanuel Nakoune1,2
- 1Institut Pasteur of Bangui, Pasteur International Network, BP 923, Avenue Pasteur, Bangui, Central African Republic
- 2University of Bangui, Faculté des Sciences de la Santé, PO box 1383, Bangui, Central African Republic
- 3Ministère de la Santé et de la Population, PO box 1383, Bangui, Central African Republic
- 4World Health Organization, Country Office in Bangui, PO box 1383, Bangui, Central African Republic
- ↵*Author for correspondence:
Alexandre Manirakiza, Email: alexandre.manirakiza{at}pasteur-bangui.cf, Telephone: (+236)72107916
Posted November 21, 2021.
Very high relative seroprevalence of anti-SARS-CoV-2 antibodies among communities in Bangui, Central African Republic
